PI-3065

CAS No. 955977-50-1

PI-3065( PI3065 | PI 3065 )

Catalog No. M16821 CAS No. 955977-50-1

A potent inhibitor of PI3K p110δ with IC50/Ki values of 5/1.5 nM respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 67 In Stock
25MG 122 In Stock
50MG 193 In Stock
100MG 321 In Stock
200MG 445 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI-3065
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent inhibitor of PI3K p110δ with IC50/Ki values of 5/1.5 nM respectively.
  • Description
    A potent inhibitor of PI3K p110δ with IC50/Ki values of 5/1.5 nM respectively; exhibits less potent activity against p110α, p110β, p110γ with IC50s of 910, 600, >10000 nM.
  • In Vitro
    PI-3065 exhibits no inhibition of the growth of 4T1 cells, which do not express detectable levels of p110δ.
  • In Vivo
    PI-3065 (75 mg/kg, p.o.) inhibits the growth of 4T1 tumours in the BALB/c mice without obvious body weight loss.
  • Synonyms
    PI3065 | PI 3065
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    DNA-PK| mTOR| p110α| p110β| p110δ
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    955977-50-1
  • Formula Weight
    506.638
  • Molecular Formula
    C27H31FN6OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO
  • SMILES
    FC1=C(C2=NC(N3CCOCC3)=C4C(C=C(CN5CCN(CC6CC6)CC5)S4)=N2)C7=C(NC=C7)C=C1
  • Chemical Name
    Thieno[3,2-d]pyrimidine, 6-[[4-(cyclopropylmethyl)-1-piperazinyl]methyl]-2-(5-fluoro-1H-indol-4-yl)-4-(4-morpholinyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ali K, et al. Nature. 2014 Jun 19;510(7505):407-11.
molnova catalog
related products
  • MOMIPP

    MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.

  • GNE-477

    A potent, dual PI3K/mTOR inhibitor with IC50 of 4 nM for PI3Kα, Ki of 21 nM for mTOR.

  • iMDK

    iMDK quarterhydrate is a potent PI3K inhibitor that inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate synergistically inhibits non-small cell lung cancer (NSCLC) with MEK inhibitors without harming normal cells and mice.